<DOC>
	<DOCNO>NCT02896101</DOCNO>
	<brief_summary>This Randomized , Double-Blind , Placebo-Controlled , Parallel-Group , Multiple-Site Study Evaluate Therapeutic Equivalence Generic Pimecrolimus Cream , 1 % ( Glenmark Pharmaceuticals Ltd ) Marketed Product ELIDEL® ( pimecrolimus ) Cream , 1 % ( Valeant Pharmaceuticals North America LLC ) Treatment Mild Moderate Atopic Dermatitis ( AD ) .</brief_summary>
	<brief_title>Study Generic Pimecrolimus Cream , 1 % Treatment Mild Moderate Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Male nonpregnant , nonlactating female subject 12 year age old . Nonimmunocompromised , clinical diagnosis mild moderate AD fail respond adequately topical prescription treatment atopic dermatitis , treatment advisable . Confirmed diagnosis AD least 3 month use diagnostic feature describe Hanifin Rajka . IGA score 2 ( mild ) 3 ( moderate ) ≥ 5 % BSA affect baseline . Active cutaneous bacterial , viral fungal infection treatment area baseline ( e.g. , clinically infected AD ) . Sunburn , extensive scarring pigment lesion ( ) treatment area baseline history presence skin condition would interfere evaluation . History presence Netherton 's Syndrome , immunological deficiency disease , organ transplant , HIV , diabetes , malignancy , malignant premalignant skin condition , serious active recurrent infection , systemic immunosuppressive regimen , clinically significant severe renal insufficiency severe hepatic disorder . Use within one month baseline 1 ) oral intravenous corticosteroid , 2 ) UVA/UVB therapy , 3 ) psoralen plus ultraviolet A therapy ( PUVA ) , 4 ) tan booth , 5 ) nonprescription ultraviolet ( UV ) light source , 6 ) immunomodulators immunosuppressive therapy , 7 ) interferon , 8 ) cytotoxic drug , 9 ) tacrolimus 10 ) pimecrolimus . Use within 14 day baseline : 1 ) systemic antibiotic , 2 ) calcipotriene vitamin D preparation , 3 ) retinoids . Use within 7 day baseline : 1 ) antihistamine , 2 ) topical antibiotic , 3 ) topical corticosteroid 4 ) topical drug product .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Mild moderate</keyword>
</DOC>